GoodNewsoftheDay

True, recent, well-sourced good news, every morning.

HealthLarge human trial1 min read

New genetic test predicts glaucoma risk years early

Scientists from QIMR Berghofer and Australia's Flinders University improved a genetic test for common glaucoma using data from millions of people.

The updated tool analyzes millions of genetic variations to create a single risk score for eye disease. Previously, the 2020 version relied on information from only eight thousand individuals with the condition. This massive new dataset now includes approximately three hundred thousand patients alongside five million others.

Researchers found that individuals in the top 10% of genetic risk face ten times the likelihood of developing open-angle glaucoma. This form of the disease causes the highest rate of blindness worldwide and often damages the optic nerve without early symptoms.

Professor Stuart MacGregor stated that most people diagnosed with the condition suffer permanent damage before medical professionals can intervene effectively. The new method helps direct eye care resources toward those who need monitoring and faster treatment immediately.

Professor Jamie Craig said this research enables a personalized approach to risk analysis for families and early-stage patients alike. The team will now focus on scaling the test for cost effectiveness and inclusion of diverse populations globally.

More health news

HealthLarge human trial1 min read

New weight-loss drug halves knee pain in trials

Two major clinical trials show a new weight-loss drug significantly reduces knee pain for patients with osteoarthritis.

· via ScienceDaily: Top Health

HealthLarge human trial1 min read

New pill offers hope for pancreatic cancer patients

A new drug called daraxonrasib has shown promise in reducing tumour size for people with advanced pancreatic cancer during a recent medical trial.

· via The Guardian: Science